ARK 21Shares Bitcoin ETF Common Shares of Beneficial Interests (BATS: ARKB)

Ultime notizie per ARK 21Shares Bitcoin ETF Common Shares of Beneficial Interests (BATS:ARKB)

In seeking to achieve its investment objective, the Trust will hold bitcoin. The Trust is sponsored by 21Shares US LLC (the Sponsor), a wholly-owned subsidiary of Amun Holdings Ltd. The Sponsor has entered into a marketing and sub-advisory agreement (the Support Services Agreement) with ARK Investment Management LLC (the Sub-Adviser) to serve as the Trusts sub-adviser and provide assistance in the marketing of the Shares.

ARK 21Shares Bitcoin ETF

Russia,Moscow,24.06.2021,Logo,Of,Financial,Investing,Fund,Ark,Invest

Equities

News

Markets

ETFs

$BTC

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

ARKF

ARKK

ARKW

COIN

CRCL

HOOD

PLTR

L&#39;asset manager liquida i big del tech e delle crypto per un clamoroso acquisto nel settore degli asset digitali. Ecco perché.

Cathie Wood scarica Coinbase e Palantir: ecco il titolo su cui punta

Etf,Btc,-,Bitcoin,Exchange,Traded,Fund,,Stock,Market,Trading

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

IBIT

MSTR

I fondi negoziati in borsa (ETF spot) sul Bitcoin (CRYPTO: BTC) negli Stati Uniti hanno registrato afflussi netti per 667,44 milioni di dollari il 19 maggio, segnando il quarto giorno consecutivo di crescita positiva.

Gli ETF su Bitcoin registrano afflussi record: cosa sta succedendo?

Bitcoin ETFs

Lunedì, gli ETF spot su Bitcoin negli Stati Uniti hanno registrato 591,3 milioni di dollari di afflussi netti, segnando il settimo giorno consecutivo di flussi positivi, mentre Bitcoin (CRYPTO: BTC) continua a essere scambiato sopra i 95.000 dollari.

Mentre gli ETF su Bitcoin volano, l&#39;Arizona vota per la prima riserva statale di BTC

ARK 21Shares Bitcoin ETF Common Shares of Beneficial Interests

JP Morgan analyst Jeffrey Zekauskas initiates coverage on Methanex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEOH#NASDAQ">MEOH</a>) with a Neutral rating and announces Price Target of $33.

Price Target

Initiation

Analyst Ratings

MEOH

JP Morgan Initiates Coverage On Methanex with Neutral Rating, Announces Price Target of $33

Jacobs Says It Has Been Selected By Bonneville Power Administration To Provide Engineering And Advisory Services For The Grand Coulee Modernization Program, An Infrastructure Supporting Largest Power-generating Dam In US

REGN climbs over 16 points after the alert
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/09204238/Screenshot-2025-06-09-at-4.39.08%E2%80%AFPM-994x1024.png" alt="" class="wp-image-14161" /></figure>
Regeneron Pharma Inc. (REGN) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at 10:16AM on June 9th, a significant trading signal occurred for Regeneron Pharma Inc., (REGN) as it demonstrated a Power Inflow at a price of $501.83. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Regeneron&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Regeneron's stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock's overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for REGN, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025">https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025</a>, which are responsible for parts of the data within this article.
The price at the time of the Power Inflow was $501.83. The returns on the High price ($517.91) and Close price ($517.60) after the Power Inflow are respectively 3.2% and 3.1%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. They were very close today, but that is not always the case.
Past performance is not indicative of future results

Technicals

Opinion

Signals

Trading Ideas

REGN

Regeneron Pharma Shares Rise Over 3% After Key Signal

Jones Trading analyst Justin Walsh initiates coverage on VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) with a Buy rating and announces Price Target of $3.

VNRX

Jones Trading Initiates Coverage On VolitionRX with Buy Rating, Announces Price Target of $3

WGRX

Wellgistics Health Announces Its Official Membership In OptiSource, A Group Purchasing Organization That Provides Innovative Business Solutions, Group Purchasing Programs, And Other Efficiency-enhancing And Cost-saving Services To Its Members

VENU's Preferred Offering gives shareholders an opportunity to earn an 8.0% dividend and to convert to VENU's common stock, traded on the NYSE American under ticker symbol VENU.
As part of the fan-owned model, shareholders can also unlock access to exclusive loyalty perks based on the level of investment, ranging from free concert tickets and custom signed guitars to unforgettable all-inclusive concert experiences.

VENU

Venu Holding Corporation Announces Preferred Offering With 8% Dividend And NYSE Access

Jefferies analyst Yaron Kinar downgrades Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) from Buy to Hold and lowers the price target from $106 to $100.

Downgrades

ACGL

Jefferies Downgrades Arch Capital Group to Hold, Lowers Price Target to $100

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4445510-1&amp;h=134772186&amp;u=https%3A%2F%2Fostherapies.com%2F&amp;a=OS+Therapies+Inc.+(NYSE-A%3A+OSTX)%C2%A0">OS Therapies Inc. (NYSE-A: OSTX)&nbsp;</a>("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, has selected <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4445510-1&amp;h=2120777306&amp;u=https%3A%2F%2Fwww.eversana.com%2F&amp;a=EVERSANA%C2%AE">EVERSANA&#xAE;</a>, a leading provider of global commercial services to the life sciences industry, to support the U.S. commercialization of OST-HER2, a novel immunotherapy for recurrent, fully resected, pediatric lung metastatic osteosarcoma.
OST-HER2, a Listeria monocytogenes-based immunotherapy, is the first potential new treatment in over 40 years for pediatric osteosarcoma, a rare, aggressive bone cancer that often metastasizes to the lungs, primarily affecting children and adolescents. The therapy has received Orphan, Fast Track and Rare Pediatric Disease Designations from the U.S. Food and Drug Administration (FDA), with a Biologics License Application (BLA) rolling submission targeted to begin in the third quarter of 2025, with potential approval coming as early as year end 2025.
EVERSANA will activate its dedicated end-to-end EVERSANA ONCOLOGY Commercialization model, including market access, medical affairs, field deployment, patient services and stakeholder engagement. The fully integrated platform accelerates awareness and access to OST-HER2 among healthcare providers treating osteosarcoma, as well as the potential to treat additional HER2-positive cancers.
The announcement follows OS Therapies' recent issuance of U.S. Patent #12,239,738, securing commercial manufacturing exclusivity for OST-HER2 and its broader Listeria-based immunotherapy platform through 2040.&nbsp;

OSTX

OS Therapies Selects EVERSANA To Support U.S. Commercialization Of OST-HER2, Immunotherapy For Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma

AMAL

Amalgamated Financial Corp. Unit Amalgamated Bank Announced The Successful Closing Of A Commercial Property Assessed Clean Energy Financing Under The Pace Massachusetts Program Using Allectrify's FASTPACE Platform

Global Partners Commences Cash Tender Offer To Purchase Any And All Of Outstanding 7.00% Senior Notes Due 2027

Cryptocurrencies are surging on Tuesday morning, with Bitcoin briefly tapping the $110,000 mark.
Optimism is being fueled by institutional accumulation and a fresh wave of regulatory clarity from the joint U.S. SEC and CFTC statement, boosting investor confidence.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$109,525.03</td>
<td>+1.9%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,714.58</td>
<td>+7%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$158.01</td>
<td>+1.4%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.27</td>
<td>+0.9%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1912</td>
<td>+3.1%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001301</td>
<td>+2.4%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows Bitcoin and Ethereum large transaction volume increased by 54.8% and 164.1% respectively. Daily active addresses are up by 17.9% and 8%. BTC's exchange netflows are down by 241.9%.</li>
<li>Coinglass data shows 102,059 traders were liquidated in the past 24 hours for $408.36 million.</li>
<li>SoSoValue data shows net outflows of $386.3 million into spot Bitcoin ETFs while Spot Ethereum ETFs saw net inflows of $52.7 million.</li>
</ul>
Trader Notes: Carl Moon, founder of a popular crypto show, warned that Bitcoin must break key resistance before the start of Q3, or risk stagnating throughout summer.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> has to break above this resistance before Q3 starts, otherwise there is a chance it just stalls out during Summer 2025. Your thoughts?&#x1f447; <a href="https://t.co/V7ez2z9iLW">pic.twitter.com/V7ez2z9iLW</a>
&mdash; Carl Moon (@TheMoonCarl) <a href="https://twitter.com/TheMoonCarl/status/1932381060584681811?ref_src=twsrc%5Etfw">June 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto Seth <a href="https://x.com/seth_fin/status/1932365201816641628">pointed </a>to a recent short squeeze as a positive development but urged caution. He expects an all-time high is on the horizon but reminds traders to apply stop-loss discipline due to potential pullbacks.
While Ethereum is heading into key resistance, crypto trader Jelle <a href="https://x.com/CryptoJelleNL/status/1932376610507755917">predicts</a> a break above $3,000 to trigger an altcoin run. Michael van de Poppe <a href="https://x.com/CryptoMichNL/status/1932358323292254210">believes</a> Ethereum is building up for a breakout after its strong consolidation of more than a month. He marks $2,575 as key area to hold and breaking the resistance at $2,800 will see the next leg to $3,400-3,500.
Crypto chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1932346746845413538">predicts</a> a break above $200 for Solana could trigger a 5x to 10x bull run.
DefiVillain argues that XRP may have already topped forever, dismissing further upside potential.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> probably topped forever <a href="https://t.co/02eEyF9L0s">pic.twitter.com/02eEyF9L0s</a>
&mdash; VIKTOR (@thedefivillain) <a href="https://twitter.com/thedefivillain/status/1932357895443660832?ref_src=twsrc%5Etfw">June 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trader Tardigrade <a href="https://x.com/TATrader_Alan/status/1932362867053142488">highlights</a> a break above key resistance, along with an imminent MACD bullish crossover, both signaling strong upside momentum.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45841991/anthony-pompliano-says-bitcoins-endgame-is-hyper-bitcoinization" target="_blank" rel="noreferrer noopener">Anthony Pompliano Says Bitcoin&#8217;s Endgame Is Hyper-Bitcoinization</a></li>
</ul>
Image: Shutterstock

$DOGE

$SHIB

$SOL

$XRP

Bitcoin, XRP, Dogecoin Up 2%, ETH Surges 7% Amid Regulatory Tailwinds

Global Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLP#NYSE">GLP</a>) ("Global") today announced that it intends to commence a private offering to eligible purchasers, subject to market and other conditions, of $400 million in aggregate principal amount of senior unsecured notes due 2033 (the "Senior Notes"). The Senior Notes will be co-issued by GLP Finance Corp. and guaranteed by certain other subsidiaries of Global.
Global intends to use the net proceeds from the offering of the Senior Notes, together with cash on hand, if necessary, to fund the purchase of its outstanding $400 million aggregate principal amount of 7.00% senior notes due 2027 (the "2027 Notes") in a cash tender offer (the "Tender Offer"). The Tender Offer is being made pursuant to an Offer to Purchase and Notice of Guaranteed Delivery, each dated June 10, 2025. To the extent the Tender Offer is not completed or is completed but Global purchases less than all of the 2027 Notes in the Tender Offer, Global intends to use any remaining net proceeds from the offering of the Senior Notes to redeem any 2027 Notes that remain outstanding on or about August 1, 2025.

Global Partners Intends To Commence Private Offering To Eligible Purchasers Of $400M In Aggregate Principal Amount Of Senior Unsecured Notes Due 2033

Royal Bank Of Canada Announced That The Toronto Stock Exchange And The Office Of The Superintendent Of Financial Institutions Have Approved Its Normal Course Issuer Bid To Purchase, For Cancellation, Up To 35M Of Its Common Shares.

ASTS

AST SpaceMobile Set To Join Russell 1000 Index, Effective June 27, As Part Of 2025 Russell Indexes Reconstitution

Core &amp; Main (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNM#NYSE">CNM</a>) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.50 by 4 percent. This is a 6.12 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $1.91 billion which beat the analyst consensus estimate of $1.85 billion by 3.27 percent. This is a 9.76 percent increase over sales of $1.74 billion the same period last year.

Earnings

Earnings Beats

Core & Main Q1 EPS $0.52 Beats $0.50 Estimate, Sales $1.91B Beat $1.85B Estimate

<ul>
<li>Reflexivity Research, a subsidiary of DeFi Technologies, has partnered with Beluga, a leading platform that makes crypto simple and easy to understand.</li>
<li>The partnership will drive joint business development, expand distribution reach, and offer co-branded research and strategic advisory services to token foundations and projects across the digital asset space.</li>
</ul>
TORONTO, June 10, 2025 /PRNewswire/ -&nbsp;DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEFT#NASDAQ">DEFT</a>) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"), is pleased to announce that its wholly owned subsidiary, Reflexivity Research LLC ("Reflexivity Research")., a leading&nbsp;crypto research firm, has entered into a strategic partnership with Beluga, a leading platform that makes crypto simple and easy to understand. This collaboration is designed to accelerate joint business development, enhance distribution reach, and deliver comprehensive research services across both retail and institutional segments.

DEFT

DeFi Technologies' Reflexivity Research Partners With Beluga To Drive Joint Business Development, Enhance Distribution Reach, And Offer Comprehensive Research Services Across Both Retail And Institutional Segments

The Space Microalgae investigation will analyze the impact of microgravity on the growth, metabolism, and genetic activity of three strains of edible microalgae, which researchers are assessing as a potential sustainable food source for long-duration space missions. For this research mission, Redwire will manage mission integration, scientific fulfillment, and on orbit operations.

Redwire Says It Is Selected By NASA To Facilitate Biotechnology Research As Part Of International Human Spaceflight Mission

ARAI

Arrive AI Says It Secured Another Key Patent For Smart Mailbox-Anchored Autonomous Last-Mile Delivery Solutions Platform

Gelteq Limited (NASDAQ:<a href="https://www.benzinga.com/stock/GELS#NASDAQ">GELS</a>) ("Gelteq" or the "Company"), a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, sports and other products, today announced a major expansion of its U.S. commercial strategy through an exclusive logistics and distribution agreement with Healthy Extracts Inc. ("Healthy Extracts")(OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/HYEX#OTCQB">HYEX</a>), a publicly traded company focused on plant-based health supplements.
The agreement names Healthy Extracts as Gelteq's exclusive North American storage, shipping, and fulfillment partner, further building on the <a href="https://www.globenewswire.com/Tracker?data=qN2e_4L23zIpYmu6fHhSl_tmWjdfB6qJL2nLGUo3xtfv-R2ukvBR1xif_vOsFRx-5ZOypavYKdkHHrYSP9V22gQ_3GAhU_om0TwlPBiEz1-gu0f5M9Aa0L2z5FddiLoRSgicJHTX14Sz4TCa682PNlSdNGK8WOcBNAr__QZBJZgcVXLUpw8WAgjHthP-SD0Oasy3fqmhFU5-fVm71QGqYUuawwODxPXu3rYeIblvmZTdTdvYgw0jilHqvTL_HuIR">earlier purchase order placed by Healthy Extracts</a> for Gelteq products. By partnering with Healthy Extracts, Gelteq expects to rapidly scale distribution of its proprietary delivery technologies across the United States and Canada while significantly reducing costs and boosting revenue potential.
Under the new agreement, Healthy Extracts will manage all product receiving, secure warehousing, inventory, and order fulfillment from its Henderson, Nevada facility, which is optimized for high-volume distribution.

GELS

HYEX

Gelteq Expands U.S. Commercial Strategy Through Exclusive Logistics And Distribution Agreement With Healthy Extracts

ETOR

eToro Group Reports Q1 Eps Of $0.69, Net Contribution Increased By 8% Year On Year To $217M

ARK 21Shares Bitcoin ETF Beneficial Interest

Comments

ARK 21Shares Bitcoin ETF Common Shares of Beneficial Interests

Notizie

Ultime notizie per ARK 21Shares Bitcoin ETF Common Shares of Beneficial Interests (BATS:ARKB)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO